Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 15, 2019

SELL
$11.76 - $22.15 $3,528 - $6,645
-300 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $69,814 - $146,998
-6,700 Reduced 95.71%
300 $3,000
Q4 2017

Feb 14, 2018

SELL
$18.0 - $30.0 $855,000 - $1.43 Million
-47,500 Reduced 87.16%
7,000 $183,000
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $1.15 Million - $1.37 Million
54,500
54,500 $1.22 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.